Sodium hyaluronate, commonly known as hyaluronic acid, with a chemical formula of (C14H20NO11Na) n, is an inherent component in the human body. It is a glucuronic acid and has no species specificity. It is widely present in tissues and organs such as placenta, amniotic fluid, crystalline lens, articular cartilage, skin dermis, etc. It is a high molecular weight polysaccharide biomaterial formed by repeated alternation of N-acetylglucuronic acid.
Sodium hyaluronate can be divided into four categories based on its molecular weight: high molecular weight sodium hyaluronate, medium molecular weight sodium hyaluronate, low molecular weight sodium hyaluronate, and oligomeric sodium hyaluronate. Sodium hyaluronate with different molecular weights has different effects and functions. For example, high molecular weight sodium hyaluronate is mainly used for moisturizing, while low molecular weight sodium hyaluronate can penetrate the epidermis and improve the hydration of the underlying skin layer.
Overview of Market Development
In recent years, the European sodium hyaluronate market has shown a steady growth trend. According to our research data, the estimated market size of sodium hyaluronate in Europe in 2024 is $642 million, an increase of 6.34% compared to 2023. In the next few years, with the continuous advancement of technology and further expansion of application fields, the market demand for sodium hyaluronate in Europe will further expand. On the other hand, the rapid growth of the Asia Pacific market may also have a positive impact on the European market. It is expected that by 2029, the market size of sodium hyaluronate in Europe will increase to $886 million. The CAGR for 2024-2029 is estimated to be 6.64%.
Analysis of Market Competition Pattern
From the perspective of market competition, the concentration of sodium hyaluronate market in Europe is relatively low. Data shows that in 2023, the total output value of sodium hyaluronate produced by the top 3 companies in the industry was $159 million, with a total output value share of 26.37%. The top three companies were Galderma (Nestl é), Evonik, and Shiseido. In 2023, the market share of sodium hyaluronate produced by these three companies in the European market was 12.11%, 10.71%, and 3.55%, respectively.
Europe Sodium Hyaluronate Market Size Forecast and Competition Pattern Analysis
Source: www.globalmarketmonitor.com
Segmented Market Analysis
From the perspective of downstream application patterns, sodium hyaluronate is mainly used in the fields of pharmaceuticals, personal care, and nutrition. Among them, the personal care field is the largest downstream application market. The data shows that the estimated consumption of sodium hyaluronate in the personal care field in 2024 is 217.5 tons, with an estimated consumption proportion of 65.73%.
From the perspective of national development, Germany is the largest consumer market for sodium hyaluronate in Europe. Data shows that the consumption of sodium hyaluronate in Germany is expected to reach 78.7 tons in 2024, accounting for an estimated 23.78% of the total consumption; The UK and French markets are expected to rank second and third with respective proportions of 16.62% and 16.26%.
Europe Sodium Hyaluronate Segment Market Size and Market Share Forecast in 2024
|
Consumption (Tons)
|
Proportion
|
Segmented by Application
|
Pharmaceuticals
|
24.5
|
7.40%
|
Personal Care
|
217.5
|
65.73%
|
Nutrition
|
88.8
|
26.84%
|
Segmented by Country
|
Germany
|
78.7
|
23.78%
|
UK
|
55.0
|
16.62%
|
France
|
53.8
|
16.26%
|
Italy
|
39.7
|
12.00%
|
Spain
|
26.5
|
8.01%
|
Poland
|
11.5
|
3.48%
|
Others
|
35.7
|
11.86%
|
Source: www.globalmarketmonitor.com
For more industry information, please refer to our latest released "2023 Global Sodium Hyaluronate Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast".